One of the Obama administration’s numerous experiments to reducethe cost of Medicare has provoked furyfrom cancer doctors.

The administration announced last month it would be tryingout a new model to reimburse doctorsand providers for the cost of medications administered atoutpatient facilities, typically expensive cancer treatments thatare delivered intravenously at cancer clinics.

The current system pays doctors the average sales prices of thedrug plus 6 percent. The new model will pay doctors the averagesales price plus 2.5 percent and a flat fee of $16.80 for every daythe medication is used.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Core and Group Health
Consumer Driven Health Care